Foresite Capital Management V, LLC: 13F holdings
CIK 17922062026Q2
| Positions | 9 |
|---|---|
| Reported value | $362.2m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| ALUMIS INC. | 5,896,995 | $165.9m | 45.8% |
| CG Oncology, Inc. | 1,079,050 | $76.7m | 21.2% |
| Disc Medicine, Inc. | 374,069 | $27.4m | 7.6% |
| HIMS Hims & Hers Health, Inc. | 738,151 | $25.6m | 7.1% |
| Pharvaris N.V. | 664,142 | $23.0m | 6.3% |
| Eikon Therapeutics, Inc. | 1,318,983 | $17.2m | 4.8% |
| Odyssey Therapeutics, Inc. | 713,105 | $13.3m | 3.7% |
| Lyell Immunopharma, Inc. | 476,386 | $6.7m | 1.8% |
| NRIX Nurix Therapeutics, Inc. | 265,000 | $6.4m | 1.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1792206")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.